GL1X · GenesisL1 explorer

Research workbench

Melanoma differentiation associated protein-5 helicase domain complex with inhibitor non-structural protein V

Analyse Melanoma differentiation associated protein-5 helicase domain complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4I1S
Type
protein
Length
290 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Melanoma differentiation associated protein-5; Non-structural protein V
UniProt
A7LCX1, P11207
Ligands
ZN
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 2 distinct chains · 52% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMelanoma differentiation associated protein-5protein23863% helix, 9% strandA7LCX1
BNon-structural protein Vprotein526% helix, 38% strandP11207

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12210.570.7935empty
21620.460.7628empty
31480.430.7523empty

Interfaces

1 interface between chains.

  • A–B · 1129 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 modified (engineered).

Compared structures

  • 4I1S · Melanoma differentiation associated protein-5 Helicase domain complex with inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.